Display options
Share it on

Can J Infect Dis Med Microbiol. 2015 Jan-Feb;26:6A-12A. doi: 10.1155/2015/983425.

Canadian Public Health Laboratory Network laboratory guidelines for the use of serological tests (excluding point-of-care tests) for the diagnosis of syphilis in Canada.

The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale

Paul N Levett, Kevin Fonseca, Raymond Sw Tsang, Kamran Kadkhoda, Bouchra Serhir, Sandra M Radons, Muhammad Morshed

Affiliations

  1. Saskatchewan Disease Control Laboratory, Regina, Saskatchewan;
  2. Alberta Provincial Laboratory for Public Health, Calgary, Alberta;
  3. National Microbiology Laboratory;
  4. Cadham Provincial Laboratory; ; Department of Medical Microbiology & Infectious Diseases and Department of Immunology, University of Manitoba, Winnipeg, Manitoba;
  5. Institut national de santé publique du Quebec-LSPQ, Sainte-Anne-de-Bellevue, Quebec;
  6. Canadian Public Health Laboratory Network, Winnipeg, Manitoba;
  7. BC Public Health Microbiology and Reference Laboratory; ; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia.

PMID: 25798165 PMCID: PMC4353981 DOI: 10.1155/2015/983425

Abstract

Syphilis, caused by the bacterium Treponema pallidum subsp. pallidum, is an infection recognized since antiquity. It was first reported at the end of the 15th century in Europe. Infections may be sexually transmitted as well as spread from an infected mother to her fetus or through blood transfusions. The laboratory diagnosis of syphilis infection is complex. Because this organism cannot be cultured, serology is used as the principal diagnostic method. Some of the issues related to serological diagnoses are that antibodies take time to appear after infection, and serology screening tests require several secondary confirmatory tests that can produce complex results needing interpretation by experts in the field. Traditionally, syphilis screening was performed using either rapid plasma reagin or Venereal Disease Research Laboratory tests, and confirmed by treponemal tests such as MHA-TP, TPPA or FTA-Abs. Currently, that trend is reversed, ie, most of the laboratories in Canada now screen for syphilis using treponemal enzyme immunoassays and confirm the status of infection using rapid plasma reagin or Venereal Disease Research Laboratory tests; this approach is often referred to as the reverse algorithm. This chapter reviews guidelines for specimen types and sample collection, treponemal and non-treponemal tests utilized in Canada, the current status of serological tests for syphilis in Canada, the complexity of serological diagnosis of syphilis infection and serological testing algorithms. Both traditional and reverse sequence algorithms are recommended and the algorithm used should be based on a combination of local disease epidemiology, test volumes, performance of the proposed assays and available resources.

Keywords: Enzyme immunoassay; RPR; Reverse algorithm; Serological diagnosis; Syphilis; Treponema pallidum

References

  1. Clin Chem. 2012 Jun;58(6):1065-6 - PubMed
  2. Can J Infect Dis Med Microbiol. 2005 Jan;16(1):45-51 - PubMed
  3. Br J Vener Dis. 1972 Feb;48(1):1-12 - PubMed
  4. Clin Infect Dis. 2014 Apr;58(8):1116-24 - PubMed
  5. South Med J. 1957 Jul;50(7):911-8 - PubMed
  6. CRC Crit Rev Clin Lab Sci. 1975 Jan;5(3):315-30 - PubMed
  7. J Clin Microbiol. 2013 Dec;51(12):4060-6 - PubMed
  8. Clin Microbiol Rev. 1995 Jan;8(1):1-21 - PubMed
  9. J Clin Microbiol. 2011 Apr;49(4):1313-7 - PubMed
  10. Int J STD AIDS. 1995 Jul-Aug;6(4):241-8 - PubMed
  11. J Clin Microbiol. 2002 Mar;40(3):973-8 - PubMed
  12. MMWR Morb Mortal Wkly Rep. 2011 Feb 11;60(5):133-7 - PubMed
  13. J Vener Dis Inf. 1946 Jul;27(7):169-74 - PubMed
  14. Sex Transm Dis. 2011 Mar;38(3):190-6 - PubMed
  15. J Infect Dis. 2013 May 1;207(9):1416-23 - PubMed
  16. Int J STD AIDS. 2008 Oct;19(10):689-93 - PubMed
  17. Public Health Rep. 1961 Oct;76:933-5 - PubMed
  18. Sex Transm Infect. 2010 Apr;86(2):97-8 - PubMed
  19. J Clin Pathol. 1992 Jan;45(1):37-41 - PubMed
  20. Int J STD AIDS. 2008 Jun;19(6):393-9 - PubMed
  21. MMWR Morb Mortal Wkly Rep. 2008 Aug 15;57(32):872-5 - PubMed
  22. J Clin Microbiol. 1983 Nov;18(5):1141-5 - PubMed
  23. Sex Transm Dis. 2009 Dec;36(12):789-93 - PubMed
  24. Public Health Rep. 1964 May;79:410-2 - PubMed
  25. Int J STD AIDS. 2009 May;20(5):300-9 - PubMed
  26. South Med J. 2004 Apr;97(4):327-8 - PubMed
  27. South Med J. 1971 May;64(5):633-4 - PubMed
  28. J Clin Microbiol. 2012 Jan;50(1):148-50 - PubMed
  29. Sex Transm Dis. 2011 Jun;38(6):528-32 - PubMed
  30. Sex Transm Dis. 2011 May;38(5):448-56 - PubMed
  31. Can J Infect Dis Med Microbiol. 2011 Fall;22(3):83-7 - PubMed
  32. Public Health Rep. 1957 Sep;72(9):761-6 - PubMed
  33. Clin Vaccine Immunol. 2010 Jun;17(6):966-8 - PubMed
  34. J Clin Microbiol. 2007 Jun;45(6):1794-7 - PubMed
  35. Clin Diagn Lab Immunol. 2001 May;8(3):534-9 - PubMed
  36. Int J STD AIDS. 2010 Feb;21(2):110-3 - PubMed
  37. Sex Transm Dis. 2012 Jul;39(7):528-30 - PubMed
  38. Public Health Rep. 1964 Jun;79:491-5 - PubMed

Publication Types